Cantor Fitzgerald Expects Increased Earnings for CVS Health

CVS Health Co. (NYSE:CVS) – Equities researchers at Cantor Fitzgerald upped their FY2025 EPS estimates for CVS Health in a research report issued on Thursday, February 13th. Cantor Fitzgerald analyst S. James now anticipates that the pharmacy operator will post earnings per share of $5.86 for the year, up from their previous forecast of $5.71. Cantor Fitzgerald has a “Overweight” rating on the stock. The consensus estimate for CVS Health’s current full-year earnings is $5.14 per share.

CVS has been the subject of several other research reports. StockNews.com raised shares of CVS Health from a “sell” rating to a “hold” rating in a research note on Thursday. UBS Group decreased their price target on shares of CVS Health from $62.00 to $59.00 and set a “neutral” rating for the company in a research note on Tuesday. Truist Financial lifted their price target on shares of CVS Health from $60.00 to $76.00 and gave the company a “buy” rating in a research note on Thursday. TD Cowen lifted their price target on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, November 25th. Finally, Wells Fargo & Company lifted their price target on shares of CVS Health from $68.00 to $73.00 and gave the company an “overweight” rating in a research note on Thursday. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $70.28.

CVS Health Stock Up 4.9 %

Shares of NYSE CVS opened at $66.35 on Friday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The company has a market cap of $83.49 billion, a P/E ratio of 16.84, a PEG ratio of 0.60 and a beta of 0.61. CVS Health has a 1 year low of $43.56 and a 1 year high of $80.75. The firm has a 50-day simple moving average of $50.71 and a two-hundred day simple moving average of $55.94.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.01%. The ex-dividend date was Thursday, January 23rd. CVS Health’s dividend payout ratio is currently 67.51%.

Institutional Investors Weigh In On CVS Health

Large investors have recently made changes to their positions in the stock. MidAtlantic Capital Management Inc. purchased a new stake in shares of CVS Health during the third quarter valued at $25,000. Livelsberger Financial Advisory purchased a new stake in shares of CVS Health during the third quarter valued at $31,000. Legacy Investment Solutions LLC purchased a new stake in shares of CVS Health during the third quarter valued at $31,000. Reston Wealth Management LLC purchased a new stake in shares of CVS Health during the third quarter valued at $32,000. Finally, Ridgewood Investments LLC lifted its position in CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.